glp-1 receptor agonists effectiveness comparison of adverse effects between glp 1 dose conversion chart

This does not mean compounded medications are categorically unavailable

16 Through both proactive and ongoing individualized therapy, pharmacists play a central role in mitigating and preventing the GI AEs associated with GLP-1 RA therapy

GLP-1 receptor agonists appear to function as neuro-metabolic modulators of reward

More time and clinical studies are needed to determine whatever long-term health benefits and cost avoidance result from prescribing and covering these drugs for weight loss

ELIXA trial included patients with recent cardiovascular event (patients with acute coronary syndrome 180 days before randomization), and although there was no benefit in MACE reduction in lixisenatide treated patients compared to placebo, results revealed cardiovascular safety of lixisenatide in this specific high risk population (38, 40)

For research use only